The Impact of Dementia on the Clinical Outcome of COVID-19: A Systematic Review and Meta-Analysis
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Background: The emergence of the coronavirus disease 2019 (COVID-19) has brought large challenges to dementia patients. We reviewed the existing literature on COVID-19 to assess the incidence and mortality of dementia comorbidities in COVID-19 patients. Objective: To investigate the impact of pre-existing dementia comorbidities on COVID-19. Methods: We searched the PubMed, Embase, and Web of Science databases for patients with preexisting dementia who were diagnosed with COVID-19. The statistical data on the prevalence and mortality of dementia comorbidities were examined. A fixed-or random-effect model was used to calculate the overall pooled risk estimates. Forest plots were generated to show the summarized results. Results: A total of 265 articles were retrieved from the three databases. After removing duplicates and performing two screenings, 10 articles were selected for meta-analysis, including 119,218 participants. Overall, the meta-analysis of the 10 studies showed that the incidence of dementia in COVID-19 patients was (R: 9%, [95% CI: 6% to 13%]). Moreover, the meta-analysis of 9 studies showed that the mortality rate of individuals with dementia after being infected with COVID-19 was higher than that of individuals with no dementia (OR: 5.17 [95% CI: 2.31 to 11.59]). Substantial heterogeneity was observed in this meta-analysis. Significant publication bias was also found. Conclusion: Emerging literature shows that dementia comorbidities are a high risk factor for the prevalence and mortality of COVID-19. Our results should have an impact on preventive interventions and encourage more targeted approaches to prioritize older people with specific risk factors, such as dementia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“People with dementia had around five times the mortality from COVID-19 (meta-analysis of 10 studies OR 5.17, 2.31- 11.59; n=119,218) compared to those without dementia (554)”
From Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission (2024) · cites this paper as [554]
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · cited 1×
“I2 ≤ 50% was considered to have little heterogeneity; I2 > 50% was considered to have substantial heterogeneity [18].”
BackgroundClinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Self-citationZhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263 · cited 1×
“Since the first case was detected in Wuhan, China in December 2019, a novel type of coronavirus named coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus2 (SARS-CoV-2) has become a global pandemic threat [1].”
BackgroundSelf-citationStang, A. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9491-z · Cited by 17,396 · cited 1×
“The Newcastle-Ottawa Scale (NOS) recommended by the Cochrane Collaboration was used to assess the methodological quality of the included studies [17].”
Method2019 Alzheimer’s disease facts and figures.
Alzheimer's Association (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.01.010 · Cited by 2,461
Nikolich-Zugich, J., Knox, K. S., Rios, C. T., Natt, B., Bhattacharya, D., & Fain, M. J. (2020) · GeroScience · doi:10.1007/s11357-020-00186-0 · Cited by 577 · cited 1×
“ties of vascular diseases [7], people with dementia”
BackgroundPreexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank Community Cohort
Atkins, J. L., Masoli, J. A. H., Delgado, J., Pilling, L. C., Kuo, C.-L., Kuchel, G. A., & Melzer, D. (2020) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glaa183 · Cited by 498 · cited 3×
“Two were conducted in the United States [19, 22], 6 were conducted in Europe [13, 14, 20, 21, 24, 25], and 2 were conducted in Asia [15, 23].”
BackgroundBrown, E. E., Kumar, S., Rajji, T. K., Pollock, B. G., & Mulsant, B. H. (2020) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2020.04.010 · Cited by 483 · cited 4×
“Our study found that 9% of patients infected with COVID19 have dementia comorbidities.”
BackgroundInfluentialClinical presentation of COVID19 in dementia patients
Bianchetti, A., Rozzini, R., Guerini, F., Boffelli, S., Ranieri, P., Minelli, G., Bianchetti, L., & Trabucchi, M. (2020) · The Journal of nutrition, health and aging · doi:10.1007/s12603-020-1389-1 · Cited by 305 · cited 3×
“Two were conducted in the United States [19, 22], 6 were conducted in Europe [13, 14, 20, 21, 24, 25], and 2 were conducted in Asia [15, 23].”
BackgroundTargeting Neuroinflammation to Treat Alzheimer’s Disease
Ardura-Fabregat, A., Boddeke, E. W. G. M., Boza-Serrano, A., Brioschi, S., Castro-Gomez, S., Ceyzériat, K., Dansokho, C., Dierkes, T., Gelders, G., Heneka, M. T., et al. (2017) · CNS Drugs · doi:10.1007/s40263-017-0483-3 · Cited by 233
Mok, V. C. T., Pendlebury, S., Wong, A., Alladi, S., Au, L., Bath, P. M., Biessels, G. J., Chen, C., Cordonnier, C., Dichgans, M., et al. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12143 · Cited by 196
Frailty and Mortality in Hospitalized Older Adults With COVID-19: Retrospective Observational Study
De Smet, R., Mellaerts, B., Vandewinckele, H., Lybeert, P., Frans, E., Ombelet, S., Lemahieu, W., Symons, R., Ho, E., Frans, J., et al. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2020.06.008 · Cited by 191 · cited 2×
“Two were conducted in the United States [19, 22], 6 were conducted in Europe [13, 14, 20, 21, 24, 25], and 2 were conducted in Asia [15, 23].”
BackgroundGiorgi Rossi, P., Marino, M., Formisano, D., Venturelli, F., Vicentini, M., Grilli, R., & the Reggio Emilia COVID-19 Working Group (2020) · PLOS ONE · doi:10.1371/journal.pone.0238281 · Cited by 171
Clinical characteristics and prognostic factors in COVID‐19 patients aged ≥80 years
Covino, M., Matteis, G. D., Santoro, M. C., Sabia, L., Simeoni, B., Candelli, M., Ojetti, V., & Franceschi, F. (2020) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.13960 · Cited by 165
A claims data-based comparison of comorbidity in individuals with and without dementia
Bauer, K., Schwarzkopf, L., Graessel, E., & Holle, R. (2014) · BMC Geriatrics · doi:10.1186/1471-2318-14-10 · Cited by 157 · cited 1×
“Compared with patients with no dementia, dementia patients are more likely to suffer from diseases such as hypertension, diabetes, and pneumonia [28].”
BackgroundImpact of COVID-19 pandemic restrictions on community-dwelling caregivers and persons with dementia.
Greenberg, N. E., Wallick, A., & Brown, L. M. (2020) · Psychological Trauma: Theory, Research, Practice, and Policy · doi:10.1037/tra0000793 · Cited by 157
Vaitheswaran, S., Lakshminarayanan, M., Ramanujam, V., Sargunan, S., & Venkatesan, S. (2020) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2020.06.026 · Cited by 143
Potential Novel Role of COVID-19 in Alzheimer’s Disease and Preventative Mitigation Strategies
Naughton, S. X., Raval, U., & Pasinetti, G. M. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-200537 · Cited by 138 · cited 1×
“One of the reasons that patients with dementia are at higher risk may be due to the presence of higher baseline inflammation [30].”
BackgroundRogers, N. T., Steptoe, A., & Cadar, D. (2017) · Scientific Reports · doi:10.1038/s41598-017-16104-y · Cited by 118
Risk factors and outcomes of COVID‐19 in New York City; a retrospective cohort study
van Gerwen, M. A. G., Alsen, M., Little, C. C., Barlow, J., Genden, E. M., Naymagon, L., & Tremblay, D. A. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26337 · Cited by 115 · cited 2×
“Two were conducted in the United States [19, 22], 6 were conducted in Europe [13, 14, 20, 21, 24, 25], and 2 were conducted in Asia [15, 23].”
BackgroundApoE e4e4 Genotype and Mortality With COVID-19 in UK Biobank
Kuo, C., Pilling, L. C., Atkins, J. L., Masoli, J. A. H., Delgado, J., Kuchel, G. A., & Melzer, D. R. (2020) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaa169 · Cited by 108
COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications
Yamamoto, V., Bolanos, J. F., Fiallos, J., Strand, S. E., Morris, K., Shahrokhinia, S., Cushing, T. R., Hopp, L., Tiwari, A., Hariri, R., et al. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-200831 · Cited by 100 · cited 3×
“Second, the poor outcome following SARS-CoV-2 infection is generally related to the “cytokine storm” [4].”
BackgroundInfluentialA Systematic Review and Meta-Analysis Examining Pneumonia-Associated Mortality in Dementia
Foley, N. C., Affoo, R. H., & Martin, R. E. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000367783 · Cited by 97 · cited 1×
“According to reports, in the absence of a pandemic, the death rate from pneumonia in dementia patients is twice as high as that of people without dementia [29].”
BackgroundHwang, J.-M., Kim, J.-H., Park, J.-S., Chang, M. C., & Park, D. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04541-z · Cited by 89 · cited 2×
“van Gerwen 2020 [23] United States cohort study 3,703 mean age: 56.”
BackgroundCorrelations between COVID-19 and burden of dementia: An ecological study and review of literature
Azarpazhooh, M. R., Amiri, A., Morovatdar, N., Steinwender, S., Ardanı, A. R., Yassi, N., Biller, J., Stranges, S., Belasi, M. T., Neya, S. K., et al. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117013 · Cited by 86 · cited 1×
“Another study using available data on dementia and COVID-19 in 185 countries found a significant correlation between the burden of dementia and COVID-19 cases [8].”
MethodThe natural history of symptomatic COVID-19 during the first wave in Catalonia
Burn, E., Tebé, C., Fernandez-Bertolin, S., Aragon, M., Recalde, M., Roel, E., Prats-Uribe, A., Prieto-Alhambra, D., & Duarte-Salles, T. (2021) · Nature Communications · doi:10.1038/s41467-021-21100-y · Cited by 80
Iaboni, A., Cockburn, A., Marcil, M. N., Rodrigues, K., Marshall, C., Garcia, M. A., Quirt, H., Reynolds, K. B., Keren, R., & Flint, A. J. (2020) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2020.04.025 · Cited by 76 · cited 1×
“than that of the general population [9,10].”
Padala, S. P., Jendro, A. M., & Orr, L. C. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113028 · Cited by 57 · cited 2×
“First, although there are considerable uncertainties and variability in the clinical prognosis of COVID-19, age and combined underlying diseases have always been the most important risk factors for a poor prognosis [26].”
BackgroundRossi, P. G., Marino, M., Formisano, D., et al. (2020) · medRxiv · doi:10.1101/2020.04.13.20063545 · Cited by 39
Miyashita, S., Yamada, T., Mikami, T., Miyashita, H., Chopra, N., & Rizk, D. (2020) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.13942 · Cited by 36 · cited 1×
“Two were conducted in the United States [19, 22], 6 were conducted in Europe [13, 14, 20, 21, 24, 25], and 2 were conducted in Asia [15, 23].”
BackgroundThe ApoE Locus and COVID-19: Are We Going Where We Have Been?
Finch, C. E., & Kulminski, A. M. (2020) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaa200 · Cited by 32
White Matter Lesions Impair Initiation of FAS Flow
Fernaeus, S., Almkvist, O., Bronge, L. H., Östberg, P., Hellström, Å., Winblad, B. G., & Wahlund, L. (2000) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051235 · Cited by 27
Role of thymopoiesis and inflamm-aging in COVID-19 phenotype
Scarpa, R., Costa, L., PUENTE, A. D., & Caso, F. (2020) · Pediatrics & Neonatology · doi:10.1016/j.pedneo.2020.04.001 · Cited by 27 · cited 1×
“It has been proven that the cytokine storm associated with COVID-19 is related to the increase in several proinflammatory cytokines, such as tumor necrosis factor-alpha, interleukin-1, and interleukin6, all of which have been identified to be elevated in dementia [31].”
BackgroundThe challenges of COVID ‐19 for people with dementia with Lewy bodies and family caregivers
Killen, A., Olsen, K., McKeith, I. G., Thomas, A. J., O'Brien, J. T., Donaghy, P. C., & Taylor, J. (2020) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5393 · Cited by 26 · cited 1×
“than that of the general population [9,10].”
Wan, Y., Wu, J., Ni, L., Luo, Q., Yuan, C., Fan, F., Liu, H., Zhang, C., Xiang, Y., & Xie, Q. (2020) · Aging · doi:10.18632/aging.103371 · Cited by 23 · cited 3×
“Wan 2020 [15] China case-control study 30 severe group: 66.”
BackgroundBurn, E., Tebé, C., Fernández‐Bertolín, S., et al. (2020) · medRxiv · doi:10.1101/2020.07.13.20152454 · Cited by 20 · cited 2×
“Hwang 2020 [24] Korea cohort study 103 mean age: 67.”
BackgroundThomson, J. A., Wang, W., Browning, C. J., & Kendig, H. L. (2010) · BMC Geriatrics · doi:10.1186/1471-2318-10-37 · Cited by 9
Cited by
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987
Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
Livingston, G., Huntley, J., Liu, K. Y., Costafreda, S. G., Selbæk, G., Alladi, S., Ames, D., Banerjee, S., Burns, A., Brayne, C., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01296-0 · Cited by 3,860
Martin, S. S., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Barone Gibbs, B., Beaton, A. Z., Boehme, A. K., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001209 · Cited by 2,800
Martin, S. S., Aday, A. W., Allen, N. B., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Bansal, N., Beaton, A. Z., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001303 · Cited by 1,080
Metadata
- Authors
- Liu, N., Sun, J., Wang, X., Zhao, M., Huang, Q., & Li, H.
- Affiliations
- Xiyuan Hospital (CN)
- Beijing University of Chinese Medicine (CN)
- Corresponding author
- Li, Hao
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2020-12-08
- Volume
- 78
- Issue
- 4
- Pages
- 1775-1782
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W3110517956
- Cited by
- 110
- References
- 37
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 24 · 2023: 26 · 2022: 32 · 2021: 17
- FWCI
- 0.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- other-oa
- Locations
- Journal of Alzheimer s Disease (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Funders
- National Science and Technology Major Project
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- COVID-19 pandemic, dementia
- MeSH terms
- COVID-19, Aged, Aged, 80 and over, Alzheimer Disease, Dementia, Female, Humans, Male, Middle Aged, Incidence, Prevalence, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.